Healthcare Services

Implantable Cardioverter Defibrillators (ICDs) Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Implantable Cardioverter Defibrillators (ICDs) Market Over The 2026–2030 Period?

The market size for implantable cardioverter defibrillators (icds) has experienced robust growth in recent years. This market is projected to expand from $3.98 billion in 2025 to $4.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.7%. Historically, this growth can be attributed to the rising incidence of sudden cardiac arrest, increasing prevalence of ventricular arrhythmias, clinical validation of icd efficacy, growing adoption in high-risk cardiac patients, and the expansion of cardiac care infrastructure.

The market for implantable cardioverter defibrillators (ICDs) is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $5.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this anticipated growth include technological innovations in smart ICDs, a rising need for remote patient monitoring, an expanding elderly demographic suffering from cardiac conditions, heightened public understanding of preventive cardiac treatments, and broader reimbursement policies for implantable devices. Key trends expected during this period encompass the wider embrace of ICDs equipped with remote monitoring capabilities, a growing inclination towards minimally invasive and wireless ICD systems, increased application of MRI-compatible implantable devices, broader uses for ICDs in managing heart failure, and greater incorporation of predictive analytics in addressing arrhythmias.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp

Which Major Factors Are Driving The Expansion Of The Implantable Cardioverter Defibrillators (ICDs) Market?

The implantable cardioverter defibrillators (ICDs) market is projected to grow due to the increasing incidence of cardiovascular diseases (CVDs). These conditions are disorders affecting the heart and blood vessels, encompassing ailments such as heart attacks, strokes, and hypertension, frequently linked to factors like poor diet, lack of physical activity, smoking, and genetics. The escalating prevalence of cardiovascular diseases is largely driven by an aging global populace, detrimental lifestyle choices, and rising rates of risk factors including obesity, diabetes, and hypertension. Implantable cardioverter defibrillators (ICDs) help in the management of CVDs by delivering life-saving electrical impulses to restore regular heart rhythms for patients prone to sudden cardiac arrest. For example, in October 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that 919,032 people died from cardiovascular disease in 2023, accounting for approximately 1 in every 3 deaths in the United States. Consequently, the rising occurrence of cardiovascular diseases (CVDs) is a primary force behind the expansion of the implantable cardioverter defibrillators (ICDs) market.

How Is The Implantable Cardioverter Defibrillators (ICDs) Market Segmented Across Key Categories?

The implantable cardioverter defibrillators (icds) market covered in this report is segmented –

1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs), Dual Chamber Implantable Cardioverter Defibrillators (ICDs), Biventricular Devices

2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications

3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs, MRI-Compatible Single Chamber ICDs, Wireless Single Chamber ICDs

2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs, MRI-Compatible Dual Chamber ICDs, Wireless Dual Chamber ICDs

3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator), Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)

What Trends Are Advancing Progress In The Implantable Cardioverter Defibrillators (ICDs) Market?

Major companies engaged in the implantable cardioverter defibrillators (ICDs) market are concentrating on technological enhancements, such as low current consumption defibrillators, to boost device efficiency, prolong battery life, and improve patient comfort. Low current consumption defibrillators are engineered to deliver electrical shocks to the heart utilizing less energy, which aids in extending battery life while ensuring effective treatment for arrhythmias. For example, in October 2023, MicroPort CRM, a France-based medical devices company, launched the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, signifying a notable progression in cardiac care technology. These devices feature innovative capabilities, including low current consumption for extended battery longevity and MRI compatibility, ensuring their suitability for patients who require imaging procedures. The ULYS ICD incorporates the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, enhancing patient safety during MRI scans. Additionally, the INVICTA lead achieved a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, highlighting its reliability and effectiveness.

Who Are The Dominant Players Shaping The Implantable Cardioverter Defibrillators (ICDs) Market Landscape?

Major companies operating in the implantable cardioverter defibrillators (icds) market are Abbott Laboratories, Medtronic Inc., Boston Scientific Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, LivaNova PLC, MicroPort Scientific Corporation, Intermedics Inc., Sorin Group S.p.A.

Read the full implantable cardioverter defibrillators (icds) market report here:

https://www.thebusinessresearchcompany.com/report/implantable-cardioverter-defibrillators-icds-global-market-report

Which Region Currently Holds The Largest Share Of The Implantable Cardioverter Defibrillators (ICDs) Market?

North America was the largest region in the implantable cardioverter defibrillators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (icds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Implantable Cardioverter Defibrillators (ICDs) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20839&type=smp

Browse Through More Reports Similar to the Global Implantable Cardioverter Defibrillators (ICDs) Market 2026, By The Business Research Company

Defibrillator Devices And Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

Automated External Defibrillators Aed Global Market Report

https://www.thebusinessresearchcompany.com/report/automated-external-defibrillators-aed-global-market-report

Cardiac Prosthetic Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795